In this study, we focus on the analysis of the interplay between the different sub-populations of CD4+ T-cells and how they participate in regulating the outcome of neuroinflammation and neurodegeneration in the context of PD, AD, ALS and MS. This evidence concerns the gene CD4 and myeloid sarcoma.